SEMA4A
From Wikipedia, the free encyclopedia
Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A
|
||||||||||||||
Identifiers | ||||||||||||||
Symbol(s) | SEMA4A; CORD10; FLJ12287; RP11-54H19.2; RP35; SEMAB; SEMB | |||||||||||||
External IDs | OMIM: 607292 MGI: 107560 HomoloGene: 8425 | |||||||||||||
|
||||||||||||||
RNA expression pattern | ||||||||||||||
Orthologs | ||||||||||||||
Human | Mouse | |||||||||||||
Entrez | 64218 | 20351 | ||||||||||||
Ensembl | ENSG00000196189 | ENSMUSG00000028064 | ||||||||||||
Uniprot | Q9H3S1 | Q62178 | ||||||||||||
Refseq | NM_022367 (mRNA) NP_071762 (protein) |
NM_013658 (mRNA) NP_038686 (protein) |
||||||||||||
Location | Chr 1: 154.39 - 154.41 Mb | Chr 3: 88.52 - 88.54 Mb | ||||||||||||
Pubmed search | [1] | [2] |
Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A, also known as SEMA4A, is a human gene.[1]
SEMA4A is a member of the semaphorin family of soluble and transmembrane proteins. Semaphorins are involved in guidance of axonal migration during neuronal development and in immune responses.[supplied by OMIM][1]
[edit] References
[edit] Further reading
- Kikutani H, Kumanogoh A (2003). "Semaphorins in interactions between T cells and antigen-presenting cells.". Nat. Rev. Immunol. 3 (2): 159–67. doi: . PMID 12563299.
- Kumanogoh A, Kikutani H (2004). "Immune semaphorins: a new area of semaphorin research.". J. Cell. Sci. 116 (Pt 17): 3463–70. doi: . PMID 12893810.
- Elhabazi A, Marie-Cardine A, Chabbert-de Ponnat I, et al. (2004). "Structure and function of the immune semaphorin CD100/SEMA4D.". Crit. Rev. Immunol. 23 (1-2): 65–81. PMID 12906260.
- Püschel AW, Adams RH, Betz H (1995). "Murine semaphorin D/collapsin is a member of a diverse gene family and creates domains inhibitory for axonal extension.". Neuron 14 (5): 941–8. PMID 7748561.
- Kumanogoh A, Marukawa S, Suzuki K, et al. (2002). "Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2.". Nature 419 (6907): 629–33. doi: . PMID 12374982.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi: . PMID 12477932.
- Clark HF, Gurney AL, Abaya E, et al. (2003). "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.". Genome Res. 13 (10): 2265–70. doi: . PMID 12975309.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40–5. doi: . PMID 14702039.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi: . PMID 15489334.
- Rual JF, Venkatesan K, Hao T, et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network.". Nature 437 (7062): 1173–8. doi: . PMID 16189514.
- Abid A, Ismail M, Mehdi SQ, Khaliq S (2006). "Identification of novel mutations in the SEMA4A gene associated with retinal degenerative diseases.". J. Med. Genet. 43 (4): 378–81. doi: . PMID 16199541.